Found: 32
Select item for more details and to access through your institution.
Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease.
- Published in:
- Bioactive Materials, 2024, v. 34, p. 138, doi. 10.1016/j.bioactmat.2023.12.010
- By:
- Publication type:
- Article
Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
- Published in:
- Bioactive Materials, 2023, v. 25, p. 527, doi. 10.1016/j.bioactmat.2022.07.021
- By:
- Publication type:
- Article
Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103<sup>+</sup> dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity.
- Published in:
- Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1670893
- By:
- Publication type:
- Article
Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1440131
- By:
- Publication type:
- Article
Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1440131
- By:
- Publication type:
- Article
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 6, p. 1271, doi. 10.3390/pharmaceutics14061271
- By:
- Publication type:
- Article
The Potential of Bovine Colostrum-Derived Exosomes to Repair Aged and Damaged Skin Cells.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 2, p. 307, doi. 10.3390/pharmaceutics14020307
- By:
- Publication type:
- Article
Extracellular Vesicles as Potential Theranostic Platforms for Skin Diseases and Aging.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 760, doi. 10.3390/pharmaceutics13050760
- By:
- Publication type:
- Article
Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 18, p. 10009, doi. 10.3390/ijms221810009
- By:
- Publication type:
- Article
Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5487, doi. 10.3390/ijms22115487
- By:
- Publication type:
- Article
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 14, doi. 10.3390/ijms22010014
- By:
- Publication type:
- Article
Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy.
- Published in:
- Advanced Functional Materials, 2018, v. 28, n. 17, p. 1, doi. 10.1002/adfm.201801301
- By:
- Publication type:
- Article
Exosome as a Vehicle for Delivery of Membrane Protein Therapeutics, PH20, for Enhanced Tumor Penetration and Antitumor Efficacy.
- Published in:
- Advanced Functional Materials, 2018, v. 28, n. 5, p. 1, doi. 10.1002/adfm.201703074
- By:
- Publication type:
- Article
Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes.
- Published in:
- Biochemical Journal, 2013, v. 450, n. 3, p. 537, doi. 10.1042/BJ20121256
- By:
- Publication type:
- Article
Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor-Derived Peptides for Regulation of Mast Cell Degranulation.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00725
- By:
- Publication type:
- Article
Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4435, doi. 10.3390/cancers13174435
- By:
- Publication type:
- Article
pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy.
- Published in:
- International Journal of Nanomedicine, 2012, v. 7, p. 2805, doi. 10.2147/IJN.S29817
- By:
- Publication type:
- Article
Investigation of the Potential Immunological Effects of Boiling Histotripsy for Cancer Treatment.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 8, p. 1, doi. 10.1002/adtp.201900214
- By:
- Publication type:
- Article
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy.
- Published in:
- Advanced Science, 2024, v. 11, n. 22, p. 1, doi. 10.1002/advs.202309917
- By:
- Publication type:
- Article
Exosome‐Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing.
- Published in:
- Advanced Science, 2019, v. 6, n. 20, p. N.PAG, doi. 10.1002/advs.201900513
- By:
- Publication type:
- Article
Boiling Histotripsy-induced Partial Mechanical Ablation Modulates Tumour Microenvironment by Promoting Immunogenic Cell Death of Cancers.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45542-z
- By:
- Publication type:
- Article
Harnessing Oncolytic Extracellular Vesicles for Tumor Cell‐Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.
- Published in:
- Small, 2023, v. 19, n. 37, p. 1, doi. 10.1002/smll.202300527
- By:
- Publication type:
- Article
Sustained Exosome‐Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation.
- Published in:
- Small, 2022, v. 18, p. 1, doi. 10.1002/smll.202200060
- By:
- Publication type:
- Article
Nanocage‐Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer.
- Published in:
- Advanced Materials, 2018, v. 30, n. 10, p. 1, doi. 10.1002/adma.201705581
- By:
- Publication type:
- Article
Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes.
- Published in:
- Advanced Materials, 2017, v. 29, n. 13, p. n/a, doi. 10.1002/adma.201605604
- By:
- Publication type:
- Article
Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.
- Published in:
- Biomaterials Research, 2023, v. 27, n. 1, p. 1, doi. 10.1186/s40824-023-00456-w
- By:
- Publication type:
- Article
Harnessing the Natural Healing Power of Colostrum: Bovine Milk‐Derived Extracellular Vesicles from Colostrum Facilitating the Transition from Inflammation to Tissue Regeneration for Accelerating Cutaneous Wound Healing.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 6, p. 1, doi. 10.1002/adhm.202102027
- By:
- Publication type:
- Article
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04607-9
- By:
- Publication type:
- Article
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs.
- Published in:
- Theranostics, 2024, v. 14, n. 14, p. 5413, doi. 10.7150/thno.97269
- By:
- Publication type:
- Article
Targeted delivery of anti-miRNA21 sensitizes PD-L1<sup>high</sup> tumor to immunotherapy by promoting immunogenic cell death.
- Published in:
- Theranostics, 2024, v. 14, n. 10, p. 3777, doi. 10.7150/thno.97755
- By:
- Publication type:
- Article
Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy (Adv. Mater. 38/2024).
- Published in:
- Advanced Materials, 2024, v. 36, n. 38, p. 1, doi. 10.1002/adma.202470304
- By:
- Publication type:
- Article
Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy.
- Published in:
- Advanced Materials, 2024, v. 36, n. 38, p. 1, doi. 10.1002/adma.202405475
- By:
- Publication type:
- Article